Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-19T12:02:59.182Z Has data issue: false hasContentIssue false

Chapter 35 - Lymphoid, myeloid, histiocytic, and dendritic cell proliferations in soft tissues

Published online by Cambridge University Press:  19 October 2016

By
Markku Miettinen
Edited by
Markku Miettinen
Markku Miettinen
Affiliation:
National Cancer Institute, Maryland
Get access
Type
Chapter
Information
Modern Soft Tissue Pathology
Tumors and Non-Neoplastic Conditions
 , pp. 941 - 974
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Primary Sources

Willemze, R, Jaffe, ES, Burg, G, et al. WHO-EORTC classification of cutaneous lymphomas. Blood 2005;105:3768–3785.Google Scholar
Swerdlow, SH, Campo, E, Harris, NL, et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.Google Scholar
LeBoit, PE, Burg, G, Weedon, D, Sarasin, A (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours. Lyon: IARC Press; 2006.Google Scholar
Chu, PG, Chang, KL, Arber, DA, Weiss, LM. Immunophenotyping of hematopoietic neoplasms. Semin Diagn Pathol 2000;17:236–256.Google Scholar
Hsi, ED, Yegappan, S. Lymphoma immunophenotyping: a new era in paraffin-section immunohistochemistry. Adv Anat Pathol 2001;8:218–239.Google Scholar
Falini, B, Mason, DY. Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry. Blood 2002;99:409–426.Google Scholar
Travis, WD, Banks, PM, Reiman, HM. Primary extranodal soft tissue lymphoma of the extremities. Am J Surg Pathol 1987;11:359–366.CrossRefGoogle ScholarPubMed
Lanham, GR, Weiss, SW, Enzinger, FM. Malignant lymphoma: a study of 75 cases presenting in soft tissue. Am J Surg Pathol 1989;13:1–10.Google Scholar

Secondary Sources

Utz, GL, Swerdlow, S. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol 1993;24:1155–1158.CrossRefGoogle ScholarPubMed
Leinweber, B, Colli, C, Chott, A, Kerl, H, Cerroni, L. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol 2004;26:4–13.CrossRefGoogle ScholarPubMed
Goodlad, JR, MacPherson, S, Jackson, R, Batstone, P, White, J; Scotland, Newcastle Lymphoma Group. Extranodal follicular lymphoma: a clinicopathologic and genetic analysis of 15 cases arising at non-cutaneous sites. Histopathology 2004;44:268–276.CrossRefGoogle ScholarPubMed
Keller, AR, Hochholzer, L, Castleman, B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670–683.Google Scholar
Kazakov, D, Fanburg-Smith, JC, Suster, S, et al. Castleman disease of the subcutis and underlying skeletal muscle: report of 6 cases. Am J Surg Pathol 2004;28:569–577.Google Scholar
Waterston, A, Bower, M. Fifty years of multicentric Castleman’s disease. Acta Oncol 2004;43:698–704.Google Scholar
Carbone, A, Gloghini, A. KSHV/HHV8-associated lymphomas. Br J Hematol 2008;140:13–24.CrossRefGoogle ScholarPubMed
Cronin, DM, Warnke, RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009;16:236–246.CrossRefGoogle ScholarPubMed
Ohgami, RS, Zhao, S, Ohgami, JK, et al. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2012;36:1619–1628.Google Scholar
Kuo, TT, Shih, LY, Chan, HL. Kimura’s disease: involvement of regional lymph nodes and distinction from angiolymphoid hyperplasia with eosinophilia. Am J Surg Pathol 1988;12:843–854.CrossRefGoogle ScholarPubMed
Li, TJ, Chen, XM, Wang, SZ, et al. Kimura’s disease: a clinicopathologic study of 54 Chinese patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:549–555.Google Scholar
Chen, H, Thompson, LD, Aguilera, NS, Abbondanzo, SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2004;28:505–513.CrossRefGoogle ScholarPubMed
Santucci, M, Pimpinelli, N, Arganini, L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. clinicopathologic and immunologic study of 83 cases. Cancer 1991;67:2311–2326.Google Scholar
Aguilera, NSI, Tomaszewski, MM, Moad, JC, et al. Cutaneous follicular center cell lymphoma: clinicopathologic study of 19 cases. Mod Pathol 2001;14:828–835.Google Scholar
Senff, NJ, Hoefnagel, JJ, Jansen, PM, et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007;25:1581–1587.Google Scholar
Vermeer, MH, Willemze, R. Recent advances in primary cutaneous B-cell lymphomas. Curr Opin Oncol 2014;26:230–236.CrossRefGoogle ScholarPubMed
Swerdlow, SH, Quintanilla-Martinez, L, Willemze, R, Kinney, MC. Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013;139:515–535.CrossRefGoogle ScholarPubMed
Xie, X, Sundram, U, Natkunam, Y, et al. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. Mod Pathol 2008;21:653–659.Google Scholar
Cerroni, L, Signoretti, S, Höfler, H, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997;21:1307–1315.Google Scholar
Tomaszewski, MM, Abbondanzo, SL, Lupton, GP. Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases. Am J Dermatopathol 2000;22:205–211.Google Scholar
Baldassano, MF, Bailey, EM, Ferry, JA, Harris, NL, Duncan, LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol 1999;23:88–96.CrossRefGoogle ScholarPubMed
Servitje, O, Gallardo, F, Estrach, T, et al. Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002;147:1147–1158.CrossRefGoogle Scholar
Cho-Vega, JH, Vega, F, Rassidakis, G, Medeiros, LJ. Primary cutaneous marginal zone B-cell lymphoma. Am J Clin Pathol 2006;125 Suppl:S38–S49.Google Scholar
Dalle, S, Thomas, L, Balme, B, Dumontet, C, Thieblemont, C. Primary cutaneous marginal zone lymphoma. Crit Rev Oncol Hematol 2010;74:156–162.CrossRefGoogle ScholarPubMed
Vermeer, MH, Geelen, FA, van Haselen, CW, et al. Primary cutaneous large B-cell lymphomas of the legs: a distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 1996;132:1304–1308.CrossRefGoogle ScholarPubMed
Kodama, K, Massone, C, Chott, A, et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005;106:2491–2497.Google Scholar
Grange, F, Beylot-Barry, M, Courville, P, et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis of 60 cases. Arch Dermatol 2007;143:1144–1150.Google Scholar
Tse, CC, Chan, JK, Yuen, RW, Ng, CS. Malignant lymphoma with myxoid stroma: a new pattern in need of recognition. Histopathology 1991;18:31–35.Google Scholar
Koo, CH, Shin, SS, Bracho, F, et al. Rosette-forming non-Hodgkin lymphomas. Histopathology 1996;29:557–563.Google Scholar
Lin, P, Jones, D, Dorfman, DM, Medeiros, LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 2000;24:1480–1490.Google Scholar
Maitra, A, McKenna, RW, Weinberg, AG, Schneider, NR, Kroft, SH. Precursor B-cell lymphoblastic lymphoma: a study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 2001;115:868–875.CrossRefGoogle ScholarPubMed
Sheibani, K, Battifora, H, Winberg, CD, et al. Further evidence that “malignant angioendotheliomatosis” is an angiotropic large-cell lymphoma. N Engl J Med 1986;314:943–948.Google Scholar
Wick, MR, Mills, SE, Scheithauer, BW, et al. Reassessment of malignant “angioendotheliomatosis”: evidence in favor of its reclassification as “intravascular lymphomatosis.” Am J Surg Pathol 1986;10:112–123.Google Scholar
Stroup, RM, Sheibani, K, Moncada, A, Purdy, LJ, Battifora, H. Angiotropic (intravascular) large cell lymphoma: a clinicopathologic study of seven cases with unique clinical presentations. Cancer 1990;66:1781–1788.Google Scholar
Jalkanen, S, Aho, R, Kallajoki, M, et al. Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. Int J Cancer 1989;44:777–782.Google Scholar
Ponzoni, M, Arrigoni, G, Gould, VE, et al. Lack of CD29 (beta integrin) and CD54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000;31:220–226.Google Scholar
Nixon, BK, Kussick, SJ, Carlon, MJ, Rubin, BP. Intravascular large B-cell lymphoma involving hemangiomas: an unusual presentation of a rare neoplasm. Mod Pathol 2005;18:1121–1126.Google Scholar
Smith, ME, Stamatakos, MD, Neuhauser, TS. Intravascular lymphomatosis presenting within angiolipomas. Ann Diagn Pathol 2001;5:103–106.Google Scholar
Matsue, K, Asada, N, Takeuchi, M, et al. A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period. Eur J Haematol 2008;80:236–244.Google Scholar
Samols, MA, Su, A, Ra, S, et al. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders. Am J Surg Pathol 2014;38:1203–1211.Google Scholar
Liu, Y, Zhang, W, An, J, Li, H, Liu, S. Cutaneous intravascular natural killer-cell lymphoma: a case report and review of the literature. Am J Clin Pathol 2014;142:243–247.Google Scholar
Crane, GM, Ambinder, RF, Shirley, CM, et al. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am J Surg Pathol 2014;38:426–432.Google Scholar
Wang, MB, Strasnick, B, Zimmerman, MC. Extranodal American Burkitt’s lymphoma of the head and neck. Arch Otolaryngol Head Neck Surg 1992;118:193–199.Google Scholar
Wright, D, McKeever, P, Carter, R. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children’s Cancer Study Group. J Clin Pathol 1997;50:128–134.Google Scholar
Bociek, RG. Adult Burkitt’s lymphoma. Clin Lymphoma 2005;6:11–20.Google Scholar
Brady, G, MacArthur, GJ, Farrell, PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 2007;60:1397–1402.Google Scholar
Said, J, Lones, M, Yea, S. Burkitt lymphoma and MYC: what else is new? Adv Anat Pathol 2014;21:160–165.Google Scholar
Bladé, J, Fernández de Larrea, C, Rosiñol, L, et al. Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol 2011;29:3805–3812.Google Scholar
Wirk, B, Wingard, JR, Moreb, JS. Extramedullary disease in plasma cell myeloma: the iceberg phenomenon. Bone Marrow Transplant 2013;48:10–18.Google Scholar
Delecluse, HJ, Anagnostopoulos, I, Dallenbach, F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413–1420.Google Scholar
Colomo, L, Loong, F, Rives, S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736–747.Google Scholar
Dong, HY, Scadden, DT, de Leval, T, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005;29:1633–1641.CrossRefGoogle ScholarPubMed
Vega, F, Chang, CC, Medeiros, LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005;18:806–815.Google Scholar
Salhany, KE, Macon, WR, Choi, JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998;22:881–893.Google Scholar
Kumar, S, Knenacs, S, Medeiros, J, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 1998;29:397–403.Google Scholar
Massone, C, Chott, A, Metze, D, et al. Subcutaneous, blastic natural killer cell (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004;28:719–735.CrossRefGoogle ScholarPubMed
Kong, YY, Dai, B, Kong, JC, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol 2008;32:1495–1502.Google Scholar
Willemze, R, Jansen, PM, Cerroni, L, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC cutaneous lymphoma group study of 83 cases. Blood 2008;111:838–845.Google Scholar
Huppmann, AR, Xi, L, Raffeld, M, Pittaluga, S, Jaffe, ES. Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer 2013;60:1165–1170.Google Scholar
Arps, DP, Patel, RM. Lupus profundus (panniculitis): a potential mimic of subcutaneous panniculitis-like T-cell lymphoma. Arch Pathol Lab Med 2013;137:1211–1215.Google Scholar
Kempf, W, Kazakov, DV, Kutzner, H. Lobular panniculitis due to Borrelia burgdorferi infection mimicking subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol 2013;35:e30–e33.Google Scholar
Chan, JK, Sin, VC, Wong, KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501–4513.Google Scholar
Ko, YH, Cho, EY, Kim, JE, et al. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to the site and EBV status. Histopathology 2004;44:480–489.Google Scholar
Stein, H, Foss, HD, Dürkop, H, et al. CD30+ anaplastic large cell lymphoma: a review of its histologic, genetic and clinical features. Blood 2000;96:3681–3695.Google Scholar
Savage, KJ, Harris, NL, Vose, JM, et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-cell Lymphoma Project. Blood 2008;111:5496–5504.Google Scholar
Amin, HN, Lai, R. Pathobiology of ALK+ anaplastic large cell lymphoma. Blood 2007;110:2259–2267.Google Scholar
Medeiros, LJ, Elenitoba-Johnson, KSJ. Anaplastic large cell lymphoma. Am J Clin Pathol 2007;127:707–722.CrossRefGoogle ScholarPubMed
Pant, V, Jambhekar, NA, Madur, P, et al. Anaplastic large cell lymphoma (ALCL) presenting as primary bone and soft tissue sarcoma: a study of 12 cases. Indian J Pathol Microbiol 2007;50:303–307.Google Scholar
Kounami, S, Shibuta, K, Yoshiyama, M, et al. Primary anaplastic large cell lymphoma of the psoas muscle: a case report and literature review. Acta Haematol 2012;127:186–188.Google Scholar
Gaiser, T, Geissinger, E, Schattenberg, T, et al. Case report: a unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscle. Diagn Pathol 2012;7:38.CrossRefGoogle ScholarPubMed
Sahoo, S, Rosen, PP, Feddersen, RM, et al. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med 2003;127:115–118.Google Scholar
Gauddet, G, Friedberg, JW, Weng, A, Pinkus, GS, Freedman, AS. Breast lymphoma associated with breast implants: two case reports and review of the literature. Leuk Lymphoma 2002;43:115–119.Google Scholar
Fritsche, FR, Pahl, S, Petersen, I, et al. Anaplastic large-cell non-Hodgkin’s lymphoma of the breast in periprosthetic localization 32 years after treatment for primary breast cancer: a case report. Virchows Arch 2006;449:561–564.Google Scholar
Roden, AC, Macon, WR, Keeney, GL, et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008;21:455–463.CrossRefGoogle ScholarPubMed
Wong, AK, Lopategui, J, Clancy, S, Kulber, D, Bose, S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol 2008;32:1265–1268.Google Scholar
Ye, X, Shokrollahi, K, Rozen, WM, et al. Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence. Mutat Res Rev Mutat Res 2014;762C:123–132.Google Scholar
Brody, GS, Deapen, D, Taylor, CR, et al. Anaplastic large cell lymphoma (ALCL) occuring in women with breast implants: analysis of 173 cases. Plast Reconstr Surg 2014;135:695–705.Google Scholar
Chan, JK, Buchanan, R, Fletcher, CD. Sarcomatoid variant of anaplastic large cell Ki-1 lymphoma. Am J Surg Pathol 1990;14:983–988.Google Scholar
Rekhi, B, Sridhar, E, Viswanathan, S, Shet, TM, Jambhekar, NA. ALK+ anaplastic large cell lymphoma with cohesive, perivascular arrangements on cytology, mimicking a soft tissue sarcoma: a report of 2 cases. Acta Cytol 2010;54:75–78.Google Scholar
Ten Berge, RL, Snijdewint, FGM, von Mensdorff-Pouilly, S, et al. MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. J Clin Pathol 2001;54:933–939.Google Scholar
Neiman, RS, Barcos, M, Berard, C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 cases. Cancer 1981;48:1426–1437.Google Scholar
Meis, JM, Butler, JJ, Osborne, BM, Manning, JT. Granulocytic sarcoma in nonleukemic patients. Cancer 1986;58:2697–2709.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Remstein, ED, Kurtin, PJ, Nascimento, AG. Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders. Am J Surg Pathol 2000;24:51–55.Google Scholar
Traweek, ST, Arbder, DA, Rappaport, H, Brynes, RK. Extramedullary myeloid tumors: an immunohistochemical and morphological study of 28 cases. Am J Surg Pathol 1993;17:1011–1019.Google Scholar
Pileri, SA, Ascani, S, Cox, MC, et al. Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007;21:340–350.Google Scholar
Paydas, S, Zorludemir, S, Ergin, M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006;47:2527–2541.Google Scholar
Hudock, J, Chatten, J, Miettinen, M. Immunohistochemical evaluation of myeloid leukemia infiltrates (granulocytic sarcomas) in formaldehyde-fixed and paraffin-embedded tissue. Am J Clin Pathol 1994;102:55–60.Google Scholar
Chen, J, Abbondanzo, SL. C-kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma. Arch Pathol Lab Med 2001;125:1448–1452.Google Scholar
Carter, MC, Metcalfe, DD, Komarow, HD. Mastocytosis. Immunol Allergy Clin North Am 2014;34:181–196.Google Scholar
Salces, IG, Alfaro, J, Sáenz DE Santamaría, MC, Sanchez, M. Scabies presenting as solitary mastocytoma-like eruption in an infant. Pediatr Dermatol 2009;26:486–488.Google Scholar
Longley, BJ, Metcalfe, DD. A proposed classification of mastocytosis incorporating molecular genetics. Hematol Oncol Clin North Am 2000;14:697–701.Google Scholar
Ma, D, Stence, AA, Bossler, AB, Hackman, JR, Bellizzi, AM. Identification of KIT activating mutations in paediatric solitary mastocytoma. Histopathology 2014;64:218–225.Google Scholar
Foucar, E, Rosai, J, Dorfman, R. Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease): review of the entity. Semin Diagn Pathol 1990;7:19–73.Google Scholar
Foucar, K, Foucar, E. The mononuclear phagocyte and immunoregulatory effector (M-PIRE) system: evolving concepts. Semin Diagn Pathol 1990;7:4–18.Google ScholarPubMed
Montgomery, EA, Meis, JM, Frizzera, G. Rosai–Dorfman disease of soft tissue. Am J Surg Pathol 1992;16:122–129.Google Scholar
Young, PM, Kransdorf, MJ, Temple, HT, Mousavi, F, Robinson, PG. Rosai–Dorfman disease presenting as multiple soft tissue masses. Skeletal Radiol 2005;34:665–669.Google Scholar
Kong, Y, Kong, J, Shi, D, et al. Cutaneous Rosai–Dorfman disease: a clinical and histopathologic study of 25 cases in China. Am J Surg Pathol 2007;31:341–350.Google Scholar
Bonetti, F, Chilosi, M, Menestrina, F, et al. Immunohistological analysis of Rosai–Dorfman histiocytosis: a disease of S-100 +CD1-histiocytes. Virchows Arch 1987;411:129–135.Google Scholar
Miettinen, M, Paljakka, P, Haveri, P, Saxén, E. Sinus histiocytosis with massive lymphadenopathy: a nodal and extranodal proliferation of S-100 protein positive histiocytes. Am J Clin Pathol 1987;88:270–277.CrossRefGoogle ScholarPubMed
Eisen, RN, Buckley, PJ, Rosai, J. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease). Semin Diagn Pathol 1990;7:74–82.Google ScholarPubMed
Liu, L, Perry, AM, Cao, W, et al. Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol 2013;140:395–402.Google Scholar
Morgan, NV, Morris, MR, Cangul, H, et al. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai–Dorfman disease. PLoS Genet 2010;6:e1000833.Google Scholar
Diamond, EL, Dagna, L, Hyman, DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease. Blood 2014;124:483–492.Google Scholar
Haroche, H, Arnaud, L, Cohen-Aubart, F, et al. Erdheim–Chester disease. Rheum Dis Clin North Am 2013;39:299–311.Google Scholar
Munoz, J, Janku, F, Cohen, PR, Kurzrock, R. Erdheim–Chester disease: characteristics and management. Mayo Clin Proc 2014;89:985–996.Google Scholar
Veyssier-Belot, C, Cacoub, P, Caparros-Lefebvre, D, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine 1996;75:157–169.Google Scholar
Eble, JN, Rosenberg, AE, Young, RH. Retroperitoneal xanthogranuloma in a patient with Erdheim–Chester disease. Am J Surg Pathol 1994;18:843–848.Google Scholar
Provenzano, E, Barter, SJ, Wright, PA, et al. Erdheim–Chester disease presenting as bilateral clinically malignant breast masses. Am J Surg Pathol 2010;34:584–588.CrossRefGoogle ScholarPubMed
Kenn, W, Eck, M, Allolio, B, et al. Erdheim–Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with a detailed radiological and immunohistochemical analysis. Hum Pathol 2000;31:734–739.Google Scholar
Haroche, J, Charlotte, F, Arnaud, L, et al. High prevalence of BRAF V600E mutations in Erdheim–Chester disease but not in other non-Langerhans cell histiocytoses. Blood 2012;120:2700–2703.Google Scholar
Vencio, EF, Jenkins, RB, Schiller, JL, et al. Clonal cytogenetic abnormalities in Erdheim–Chester disease. Am J Surg Pathol 2007;31:319–321.Google Scholar
Chetritt, J, Paradis, V, Dargere, D, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol 1999;30:1093–1096.Google Scholar
Lieberman, PH, Jones, CR, Steinman, RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol 1996;20:519–552.Google Scholar
Kapur, P, Erickson, C, Rakheja, D, Carder, KR, Hoang, MP. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children’s Medical Center. J Am Acad Dermatol 2007;56:290–294.Google Scholar
O’Malley, DP, Duong, A, Barry, TS, et al. Co-occurrence of Langerhans cell histiocytosis and Rosai–Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol 2010;23:1616–1623.Google Scholar
Haupt, R, Minkov, M, Astigarraga, I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer 2013;60:175–184.Google Scholar
Henck, ME, Simpson, EL, Ochs, RH, Eremus, JL. Extraskeletal soft tissue masses of Langerhans’ cell histiocytosis. Skeletal Radiol 1996;25:409–412.Google Scholar
Singhi, AD, Montgomery, EA. Gastrointestinal tract Langerhans cell histiocytosis: a clinicopathologic study of 12 patients. Am J Surg Pathol 2011;35:305–310.Google Scholar
Emile, JF, Wechsler, J, Brousse, N, et al. Langerhans’ cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 1995;19:636–641.Google Scholar
Sholl, LM, Hornick, JL, Pinkus, GS, Padera, RF. Immunohistochemical analysis of langerin in Langerhans’ cell histiocytosis and pulmonary infectious and inflammatory diseases. Am J Surg Pathol 2007;31:947–952.Google Scholar
Lau, SK, Chu, PG, Weiss, LM. Immunohistochemical expression of langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 2008;32:615–619.Google Scholar
Badalian-Very, G, Vergilio, JA, Degar, BA, et al. Recurrent BRAF mutation in Langerhans cell histiocytosis. Blood 2010;116:1919–1923.Google Scholar
Brown, NA, Furtado, LV, Betz, BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 2014;124:1655–1658.Google Scholar
Nelson, DS, Quispel, W, Badalian-Very, G, et al. Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood 2014;123:3152–3155.Google Scholar
Willman, CL, Busque, L, Griffith, BB, et al. Langerhans’-cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med 1994;331(3):154–160.Google Scholar
Cohen, BA, Hood, A. Xanthogranuloma: a report on clinical and histologic findings in 64 patients. Pediatr Dermatol 1989;6:262–266.Google Scholar
Janney, CG, Hurt, MA, Santa Cruz, DJ. Deep juvenile xanthogranuloma: subcutaneous and intramuscular forms. Am J Surg Pathol 1991;15:150–159.Google Scholar
de Graaf, JH, Timens, W, Tamminga, RYJ, Molenaar, WM. Deep juvenile xanthogranuloma: a lesion related to dermal indeterminate cells. Hum Pathol 1992;23:905–910.Google Scholar
Zelger, B, Cerio, R, Orchard, G, Wilson-Jones, E. Juvenile and adult xanthogranuloma: a histological and immunohistochemical comparison. Am J Surg Pathol 1994;18:126–135.Google Scholar
Janssen, D, Harms, D. Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel pediatric tumor registry. Am J Surg Pathol 2005;29:21–28.Google Scholar
Dehner, L. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol 2003;27:579–593.Google Scholar
Nascimento, AG. A clinicopathologic and immunohistochemical comparative study of cutaneous and intramuscular forms of juvenile xanthogranuloma. Am J Surg Pathol 1997;21:645–652.Google Scholar
Zvulunov, A, Barak, Y, Metzker, A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis. Arch Dermatol 1995;131(8):904–908.Google Scholar
Cambiaghi, S, Restano, L, Caputo, R. Juvenile xanthogranuloma associated with neurofibromatosis. 1: 14 patients without evidence of hematologic malignancies. Pediatr Dermatol 2004;21:97–101.Google Scholar
Kraus, MD, Haley, JC, Ruiz, R, et al. “Juvenile” xanthogranuloma: an immunophenotypic study with a reappraisal of its histogenesis. Am J Dermatopathol 2001;23:104–111.Google Scholar
Purvis, WE, Helwig, EB. Reticulohistiocytic granuloma (“reticulohistiocytoma”) of the skin. Am J Clin Pathol 1955;24:1005–1015.Google Scholar
Zelger, B, Cerio, R, Soyer, HP, et al. Reticulohistiocytoma and multicentric reticulohistiocytosis. Am J Surg Pathol 1994;16:577–584.Google Scholar
Miettinen, M, Fetsch, JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol 2006;30:521–528.Google Scholar
Barrow, MV, Holubar, K. Multicentric reticulohistiocytosis: a review of 33 patients. Medicine (Baltimore) 1969;48:287–305.Google Scholar
Trotta, F, Castellino, G, Lo Monaco, A. Multicentric reticulohistiocytosis. Best Pract Res Clin Rheumatol 2004;18:759–772.Google Scholar
Salisbury, JR, Hall, PA, Williams, HC, Mangi, MH, Mufti, GJ. Multicentric reticulohistiocytosis: detailed immunophenotyping confirms macrophage origin. Am J Surg Pathol 1990;14:687–693.Google Scholar
Kapadia, SB, Enzinger, FM, Heffner, DK, Hyams, VJ, Frizzera, G. Crystal-storing histiocytosis associated with lymphoplasmacytic neoplasms: report of three cases mimicking adult rhabdomyoma. Am J Surg Pathol 1993;17:461–467.Google Scholar
Jones, D, Bhatia, VK, Krausz, T, Pinkus, GS. Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol 1999;30:1441–1448.Google Scholar
Friedman, MT, Molho, L, Valderrama, E, et al. Crystal-storing histiocytosis associated with a lymphoplasmacytic neoplasm mimicking adult rhabdomyoma: a case report and review of the literature. Arch Pathol Lab Med 1996;120:1133–1136.Google Scholar
Wilson, MS, Weiss, LM, Gatter, KC, et al. Malignant histiocytosis: a reassessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer 1990;66:530–536.Google Scholar
Michgrub, S, Kamel, OW, Wiley, E, et al. Malignant histiocytic neoplasms of the small intestine. Am J Surg Pathol 1992;16:11–20.Google Scholar
Miettinen, M, Fletcher, CD, Lasota, J. True histiocytic lymphoma of small intestine: analysis of two S-100 protein positive cases with features of interdigitating reticulum cell sarcoma. Am J Clin Pathol 1993;100:285–292.Google Scholar
Soria, C, Orradre, JL, Garcia-Almagro, D, et al. True histiocytic lymphoma (monocytic sarcoma). Am J Dermatopathol 1992;14:511–517.Google Scholar
Lauritzen, AF, Delsol, G, Hansen, NE, et al. Histiocytic sarcomas and monoblastic leukemias: a clinical, histologic, and immunophenotypic study. Am J Clin Pathol 1994;102:45–54.Google Scholar
Kamel, OW, Gocke, CD, Kell, DL, Cleary, ML, Warnke, RA. True histiocytic lymphoma: a study of 12 cases based on current definition. Leuk Lymphoma 1995;18:81–86.Google Scholar
Copie-Bergman, C, Wotherspoon, AC, Norton, AJ, Diss, TC, Isaacson, PG. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol 1998;22:1386–1392.Google Scholar
Hornick, JL, Jaffe, ES, Fletcher, CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004;28:1133–1144.Google Scholar
Vos, JA, Abbondanzo, SL, Barekman, CL, et al. Histiocytic sarcoma: a study of five cases including the histiocytic marker CD163. Mod Pathol 2005;18:693–704.Google Scholar
Wang, E, Papalas, J, Hutchinson, CB, et al. Sequential development of histiocytic sarcoma and diffuse large B-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual. Am J Surg Pathol 2011;35:457–463.Google Scholar
Feldman, AL, Arber, DA, Pittaluga, S, et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008;111:5433–5439.Google Scholar
Takahashi, E, Nakamura, S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop 2013;53:1–8.Google Scholar
Venkataraman, G, McClain, KL, Pittaluga, S, Rao, VK, Jaffe, ES. Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. Am J Surg Pathol 2010;34:589–594.Google Scholar
Monda, L, Warnke, R, Rosai, J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation: a report of 4 cases. Am J Pathol 1986;122:562–572.Google Scholar
Chan, JKC, Fletcher, CDM, Nayler, SJ, Cooper, K. Follicular dendritic cell sarcoma: clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 1997;79:294–313.Google Scholar
Chan, JK. Proliferative lesions of follicular dendritic reticulum cells: an overview including a detailed account of follicular dendritic reticulum cell sarcoma, and neoplasm with many faces and uncommon etiologic associations. Adv Anat Pathol 1997;4:387–411.Google Scholar
Perez-Ordonez, B, Erlandson, RA, Rosai, J. Follicular dendritic reticulum cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 1996;20:944–955.Google Scholar
Kairouz, S, Hashash, J, Kabbara, W, McHayleh, W, Tabbara, IA. Dendritic cell neoplasms: an overview. Am J Hematol 2007;82:924–928.Google Scholar
Fonseca, R, Yamakawa, M, Nakamura, S, et al. Follicular dendritic reticulum cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998;59:161–167.Google Scholar
Biddle, DA, Ro, JY, Yonn, GS, et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol 2002;15:50–58.Google Scholar
Grogg, KL, Lae, ME, Kurtin, PJ, Macon, WR. Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 2004;28:988–998.Google Scholar
Yu, H, Gibson, JA, Pinkus, GS, Hornick, JL. Podoplanin (D2–40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol 2007;128:776–782.Google Scholar
Yu, H, Gibson, JA, Pinkus, GS, Hornick, JL. Podoplanin (D2–40) is a novel marker for follicular dendritic cell tumors. Am J Clin Pathol 2007;128:776–782.Google Scholar
Weiss, L, Berry, G, Dorfman, RF, et al. Spindle cell neoplasms of lymph nodes of probably reticulum cell lineage: true reticulum cell sarcoma? Am J Surg Pathol 1990;14:405–414.Google Scholar
Gaertner, EM, Tsokos, M, Derringer, GA, et al. Interdigitating dendritic cell sarcoma: a report of four cases and review of the literature. Am J Clin Pathol 2001;115:589–597.Google Scholar
Andriko, JW, Kaldjian, EP, Tsokos, M, Abbondanzo, SL, Jaffe, ES. Reticulum cell neoplasms of lymph nodes: a clinicopathologic study of 11 cases with recognition of a new subtype derived from fibroblastic reticular cells. Am J Surg Pathol 1998;22:1048–1058.Google Scholar
Gould, VE, Warren, WH, Faber, LP, Kuhn, C, Franke, WW. Malignant cells of epithelial phenotype limited to thoracic lymph nodes. Eur J Cancer 1990;26:1121–1126.Google Scholar
Franke, WW, Moll, R. Cytoskeletal components of lymphoid organs. I. Synthesis of cytokeratins 8 and 18 and desmin in subpopulations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation 1987;36:145–163.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×